COMING UP | WEBINAR 4

PUBLIC HEALTH AND POLICY RESPONSES TO NAFLD/NASH

JUNE 14, 2022 - 17.00 - 18.00 CET

Topic: This webinar by professor Lazarus will focus on the impact of NAFLD and NASH and what is currently being done to tackle this disease nationally and globally. During his talk, the speaker will identify what still needs to be done in the fight against NAFLD/NASH and how countries can advance the battle against this “silent” condition.
​​
Speaker: Prof. Dr. Jeffrey Lazarus, M.D.
Host: Prof. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Guest Speaker
Prof. Dr. Jeffrey Lazarus

WEBINAR 3 | Non-invasive diagnosis and disease staging of nafld 

​MARCH 22, 2022 - 17.00 - 18.00 CET

​Topic: Given the high prevalence of NAFLD in the general population, identifying the persons at a high risk for development of cirrhosis is key. This talk by Professor Hannes Hagström will focus on methods and strategies to achieve this in different settings.

Speaker: Prof. Hannes Hagström
Host: Prof. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Guest Speaker
Prof Hannes Hagström

WEBINAR 2 | Promising phase 2 trial results of Lanifibranor in NASH 

February 1, 2022 - 17.00 - 18.00 CET

​Topic:
In this webinar Prof. Sven Francque discussed the phase 2 trial results of the Pan-PPAR Agonist Lanifibranor in nonalcoholic steatohepatitis (NASH) patients. Currently there is an unmet need of management of NASH. Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that modulates key metabolic, inflammatory, and fibrogenic pathways in the pathogenesis of NASH and shows promising results as treatment.
​
Speaker: Prof. Sven Francque
Host: Dr. Manuel Castro Cabezas
Co-host: Prof. Christophe Moreno
Guest Speaker
Prof Sven Francque

WEBINAR 1 | NAFLD: Patient Identification strategies

NOVEMBER 9, 2021 - 17.00 - 18.00 CET

Topic:
In this webinar Prof. Jörn Schattenberg discussed his paper in Nature Reviews Gastroenterology & Hepatology on effective and efficient models of care for patients with NAFLD. Standardized patient care pathways for NAFLD are not yet widely implemented and therefore this represents an unmet clinical need. Professor Schattenberg’s paper includes recommendations to address the increasing need for comprehensive models of care for NAFLD.

Speaker:   Prof. Jörn Schattenberg
Host:         Dr. Manuel Castro Cabezas
Co-host:   Prof. Christophe Moreno
Guest Speaker
Prof Jörn Schattenberg

​​NASH Webinar Series
These webinars are part of the NASH webinar series, each focusing on recent developments or publications on nonalcoholic steatohepatitis (NASH). The topics and publications are selected by KOLs of NASH Clinical based on relevant ground-breaking NASH research in a high-impact journal. During these webinars we offer you the opportunity to interact with original authors and experts in the NASH field.
       HOST
​
​Assoc. Prof. Dr. Manuel Castro Cabezas, M.D.
Internist-endocrinologist/vascular specialist at Franciscus Gasthuis Ziekenhuis, Rotterdam as well as Associate Professor of Medicine at Erasmus Medical Center, Rotterdam, the Netherlands
       CO-HOST

​Prof. Dr. Christophe Moreno, M.D.
Professor in Gastroenterology and Hepatology as well as Clinical Director of the Liver Unit at CUB Hôpital Erasme, Brussels, Belgium